These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32317400)

  • 1. Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme.
    Meyer T; Kettemann D; Maier A; Grehl T; Weyen U; Grosskreutz J; Steinbach R; Norden J; George A; Hermann A; Guenther R; Petri S; Schreiber-Katz O; Dorst J; Ludolph AC; Walter B; Münch C; Spittel S
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):783-785. PubMed ID: 32317400
    [No Abstract]   [Full Text] [Related]  

  • 2. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a multimodal effect of riluzole in patients with ALS?
    de Jongh AD; van Eijk RPA; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1183-1184. PubMed ID: 30846539
    [No Abstract]   [Full Text] [Related]  

  • 5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of amyotrophic lateral sclerosis with riluzole.
    Neatherlin JS
    J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole use during pregnancy in a patient with amyotrophic lateral sclerosis: a case report.
    Kawamichi Y; Makino Y; Matsuda Y; Miyazaki K; Uchiyama S; Ohta H
    J Int Med Res; 2010; 38(2):720-6. PubMed ID: 20515588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole treatment in advanced ALS.
    Borasio GD
    J Neurol; 2002 May; 249(5):505-6. PubMed ID: 12021937
    [No Abstract]   [Full Text] [Related]  

  • 10. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
    Kollewe K; Dengler R; Petri S
    Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-modifying treatment of amyotrophic lateral sclerosis.
    Schultz J
    Am J Manag Care; 2018 Aug; 24(15 Suppl):S327-S335. PubMed ID: 30207671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course of the disease.
    Silani V
    J Neurol Sci; 2024 Jun; 461():123038. PubMed ID: 38761668
    [No Abstract]   [Full Text] [Related]  

  • 16. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis?
    Mitsumoto H
    Ann Pharmacother; 1997 Jun; 31(6):779-81. PubMed ID: 9184724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ideas for therapy in ALS.
    Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):3-4. PubMed ID: 16036419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.